Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-850-2 | CAS number: 133855-98-8 BAS 480 F
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- not specified
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- EC Number:
- 406-850-2
- EC Name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- Cas Number:
- 133855-98-8
- Molecular formula:
- C17 H13 Cl F N3 O
- IUPAC Name:
- 1-{[(2R,3R)-3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River GmbH, WIGA, 8741 Sulzfeld, Germany
- Age at study initiation: not specified
- Weight at study initiation: 28 g (mean)
- Assigned to test groups randomly: yes (with the help of an appropriate computer program)
- Fasting period before study: not specified
- Housing: 5 animals/cage during acclimation period; single housing during test period
- Diet: Kliba Haltungsdiät, ad libitum
- Water: drinking water, ad libitum
- Acclimation period: approx. 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: not specified
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- - Vehicle(s)/solvent(s) used: aqueous 0.5 % CMC formulation
- Justification for choice of solvent/vehicle: not specified
- Concentration of test material in vehicle: 25 g/100 mL (high dose group), 5 g/100 mL (mid dose group) or 1 g/100 mL (low dose group)
- Amount of vehicle (if gavage or dermal): 20 mL/kg bw - Details on exposure:
- - applied dosage volume: 20 mL/kg bw (vehicle group and dosage groups), 10 mL/kg bw (positive control)
PREPARATION OF DOSING SOLUTIONS:
- Frequency of treatment:
- one single treatment
Doses / concentrationsopen allclose all
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- high dose group: 15
other treatment groups, vehicle control group and positive control group cyclophosphamide: 5
positive control group vincristine: 3 males and 2 females - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide, dissolved in aqua dest.
- Justification for choice of positive control(s): positive control for clastogenicity
- Route of administration: oral
- Doses / concentrations: 20 mg/kg bw in a volume of 10 mL/kg bw
vincristine, dissolved in aqua dest.
- Justification for choice of positive control(s): positive control for spindle poison effects
- Route of administration: intraperitoneal
- Doses / concentrations: 0.15 mg/kg bw in a volume of 10 mL/kg bw
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The doses were selected based on the results of a pretest for the determination of the acute oral toxicity. Herein, the highest applicable dose of 5000 mg/kg bw was survived by all animals but led to signs of toxicity such as irregular respiration, apathy and abdominal position. Therefore, a dose of 5000 mg/kg bw was selected as the highest dose in the present cytogenetic study. 1000 mg/kg bw and 200 mg/kg bw were administered as further doses.
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): sacrifice intervals: 16 h (high dose group), 24 h (all groups), 48 h (high dose group)
DETAILS OF SLIDE PREPARATION: The two femora were prepared from the animals and all soft tissues were removed. After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum (37°C; about 2 mL/femur). The suspension was mixed thoroughly with a pipette, centrifuged at 1500 rpm for 5 minutes, the supernatant
was removed except for a few drops and the precipitate was resuspended. 1 drop of this suspension was dropped onto clean microscopic slides using a Pasteur pipette. Smears were prepared using slides with ground edges, the preparations were dried in the air and subsequently stained. The slides were stained in eosin and methylene blue solution for 5 minutes, rinsed in aqua dest. and then placed in fresh aqua dest. for 2 or 3 minutes. They were finally stained in Giemsa solution for 12 minutes. After being rinsed twice in aqua dest. and clarified in xylene, the preparations were embedded in Corbit-Balsam.
METHOD OF ANALYSIS: In general, 1000 polychromatic erythrocytes from each of the male and female animals of every test group were evaluated and investigated for micronuclei. Normochromatic erythrocytes (= normocytes) were also scored. The following parameters were recorded:
- number of polychromatic erythrocytes
- number of polychromatic erythrocytes containing micronuclei
- number of normochromatic erythrocytes
- number of normochromatic erythrocytes containing micronuclei
- ratio of polychromatic to normochromatic erythrocytes
- number of small micronuclei (d < D/4) and of large micronuclei (d >= D/4) (d = diameter of micronucleus, D = cell diameter) - Statistics:
- A detailed statistical evaluation was not necessary to perform as the rate of micronucleated polychromatic erythrocytes after test substance treatment was nearly in the range of the actual control values and within the range of that of the historical control values.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
- Clinical examination: at 200 mg/kg bw irregular respiration; at 1000 mg/kg bw irregular respiration and apathy, abdominal position (in a few cases); at 5000 mg/kg bw irregular respiration, abdominal position, apathy, staggering (in a few cases), poor general state, 4 animals died; no clinical signs were observed on the day after treatment
- Induction of micronuclei:
vehicle control - 1.6 % polychromatic erythrocytes containing micronuclei after the 24-hour sacrifice interval;
high dose group (5000 mg/kg bw) - 1.8 %, 2.3 % and 1.3 % polychromatic erythrocytes containing micronuclei were found after 16 h, 24 h and after 48 h, respectively;
mid dose group (1000 mg/kg bw) - 1.5 % polychromatic erythrocytes containing micronuclei were found after the 24-hour sacrifice interval;
low dose group (200 mg/kg bw) - 2.8 % polychromatic erythrocytes containing micronuclei were found after the 24-hour sacrifice interval;
positive control cyclophosphamide - 16.1 % polychromatic erythrocytes containing exclusively small micronuclei after the 24-hour sacrifice interval;
positive control vincristine - 98.6 % polychromatic erythrocytes containing the expected amount of large micronuclei after the 24-hour sacrifice interval;
The number of normochromatic erythrocytes containing micronuclei did not differ to any appreciable extent in the negative control or in the various dose groups at any of the sacrifice intervals;
No inhibition of erythropoiesis induced by the treatment of mice with the test substance was detected.
- Ratio of PCE/NCE: The ratio of polychromatic to normochromatic erythrocytes was always in the same range as that of the control values in all dose groups.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.